#SEMA4D - Twitter Hashtag

about 3 years ago

Amazing data from Dr. Liz Evans @Vaccinex on #sema4d blockade - B and myeloid cell modulator to elicit antitumor action at Keystone #ksblymph23

LesinskiLab's tweet photo. Amazing data from Dr. Liz Evans @Vaccinex on #sema4d blockade - B and myeloid cell modulator to elicit antitumor action at Keystone #ksblymph23 https://t.co/H0hrt2Je1B

0

8

1

0

709

Science Signaling @scisignal

almost 4 years ago

New findings from a team at @osaka_univ_e identify the protein #Sema4D as a proinflammatory cytokine in joints—contributing to a broader understanding of the factors that drive joint degeneration in diseases such as arthritis. #Physiology https://t.co/PPaiTs36UO

scisignal's tweet photo. New findings from a team at @osaka_univ_e identify the protein #Sema4D as a proinflammatory cytokine in joints—contributing to a broader understanding of the factors that drive joint degeneration in diseases such as arthritis. #Physiology https://t.co/PPaiTs36UO https://t.co/4gsU4Dqk9d

0

2

0

Titi Valk @TitiValk

over 5 years ago

#pepinemab #SEMA4D de #vaccinex $VCNX associé a #bavencio pour traiter le cancer du poumon a un effet fort. https://t.co/PVyNBhErEB @Vaccinex

TitiValk's tweet photo. #pepinemab #SEMA4D de #vaccinex $VCNX associé a #bavencio pour traiter le cancer du poumon a un effet fort. https://t.co/PVyNBhErEB @Vaccinex https://t.co/qqhXyHNLBJ

0

5

0

Vaccinex @Vaccinex

about 6 years ago

Richard A. Stein from @GENbio spoke with our CEO, Maurice Zauderer, who discussed how our investigational drug, pepinemab, targets #SEMA4D to potentially slow or prevent neurodegenerative disease progression. Read the full article here: https://t.co/Nu3Vj94O5N

Vaccinex's tweet photo. Richard A. Stein from @GENbio spoke with our CEO, Maurice Zauderer, who discussed how our investigational drug, pepinemab, targets #SEMA4D to potentially slow or prevent neurodegenerative disease progression. Read the full article here: https://t.co/Nu3Vj94O5N https://t.co/jwM42Zs7br

0

5

3

0

EMBO Mol. Medicine @EmboMolMed

almost 7 years ago

JH. Wu, B. Hu & coll. from the Huazhong Univ. of Science and Technology find that inhibiting the #Sema4D / #PlexinB1 axis alleviates #VascularDysfunction in #diabeticretinopathy #neovascularization #pericyte #retina anti-#VEGF Read now #openaccess: https://t.co/YdsB0u0JCD

EmboMolMed's tweet photo. JH. Wu, B. Hu & coll. from the Huazhong Univ. of Science and Technology find that inhibiting the #Sema4D / #PlexinB1 axis alleviates #VascularDysfunction in #diabeticretinopathy
#neovascularization #pericyte #retina anti-#VEGF

Read now #openaccess: https://t.co/YdsB0u0JCD https://t.co/nrAKIqUinr

0

3

1

0

Biotech-Spain.com @Biotech_Spain

over 7 years ago

📲 Researchers at IDIBELL-ICO describe a new resistance mechanism to therapies that prevent the formation of blood vessels. Read news on 👉https://t.co/aNsGNjLSyD 🚩@idibell_cat 🆕 #resistance #therapies #BloodVessels #Sema4D

Biotech_Spain's tweet photo. 📲 Researchers at IDIBELL-ICO describe a new resistance mechanism to therapies that prevent the formation of blood vessels. Read news on 👉https://t.co/aNsGNjLSyD

🚩@idibell_cat 🆕 #resistance #therapies #BloodVessels #Sema4D https://t.co/4tunZHZDWE

0

5

1

0

Biotech-Spain.com @Biotech_Spain

over 7 years ago

📲 Investigadores del IDIBELL-ICO describen un nuevo mecanismo de resistencia a terapias que impiden la formación de vasos sanguíneos. Leer noticia en 👉https://t.co/sooKqOCEhd 🚩@idibell_cat 🆕 #resistencia #terapias #VasosSanguíneos #Sema4D